The enzymatic machinery of L-histidine biosynthesis in Corynebacterium glutamicum is characterized by high catalytic efficiency, precise substrate specificity, and complex allosteric regulation. Each of the ten enzymatic steps is mediated by a dedicated enzyme or multifunctional protein, many of which exhibit unique structural features that distinguish them from their homologues in other organisms. This review provides a detailed analysis of the catalytic mechanisms, kinetic parameters, and three-dimensional structures of key enzymes, with particular emphasis on ATP phosphoribosyltransferase (HisG), imidazoleglycerol-phosphate synthase (HisFH), and histidinol-phosphate phosphatase (HisN).
ATP phosphoribosyltransferase (HisG) catalyzes the first committed step: the condensation of ATP and phosphoribosyl pyrophosphate (PRPP) to form phosphoribosyl-ATP (PR-ATP) and pyrophosphate (PPi). HisGCg belongs to the long form of ATP-PRTs, consisting of 281 amino acids, and functions as a monomer in solution. It adopts an L-shaped architecture composed of three distinct domains: two catalytic domains forming the active site cleft, and a regulatory domain capable of binding L-histidine. The active site lies at the interface between the first two domains, where PRPP and ATP bind cooperatively. Kinetic analysis reveals a specific activity of 2.19 ± 0.09 mmol·min⁻¹·mg⁻¹, a Km for PRPP of 0.08 ± 0.01 mM, and a Km for ATP of 0.22 ± 0.02 mM. The kcat value is 1.91 ± 0.14 s⁻¹, indicating moderate turnover. Notably, HisGCg exhibits non-competitive inhibition by L-histidine with a Ki of 0.11 ± 0.02 mM, consistent with feedback control.
Structural modeling based on the crystal structure of Mycobacterium tuberculosis HisGMt (62% sequence identity) predicts a nearly identical fold for HisGCg. The regulatory domain binds histidine through interactions with residues Gln215, Leu231, Thr235, Met250, and Ala270. Mutation studies confirm these residues are critical for feedback inhibition: a triple mutant (N215K/L231F/T235A) displays significantly reduced sensitivity to histidine (Ki = 4.15 ± 0.21 mM) while retaining full catalytic activity. This makes HisG an ideal target for engineering histidine-overproducing strains. Furthermore, gel filtration experiments show that HisGCg exists in equilibrium between dimeric (active) and hexameric (inactive) forms. Histidine promotes hexamer formation, which can be reversed by excess PRPP, suggesting a dynamic allosteric switch.
Imidazoleglycerol-phosphate synthase (HisFH) performs the fifth step: the conversion of PRFAR to imidazole-glycerol phosphate (IGP) and 1-(5-phosphoribosyl)-5-amino-4-imidazolecarboxamide (AICAR). In E. coli and S. typhimurium, this reaction requires a heterodimeric complex of HisF (synthase subunit) and HisH (glutaminase subunit), which channels ammonia from glutamine directly into the active site. However, in C. glutamicum, deletion of hisH does not impair growth, suggesting functional redundancy or alternative mechanisms. Biochemical evidence indicates that HisFCg alone can catalyze the reaction under physiological conditions, likely via ammonia-dependent substrate amination. This phenomenon may be attributed to the ability of HisFCg to utilize ambient NH₃ when glutamine is unavailable, a feature absent in other species.
Structurally, HisFCg shares significant similarity with HisFEc but lacks the N-terminal glutaminase domain.Tiropramide MedChemExpress Despite this, it retains the ability to complement both hisF and hisH deletions in E.Butylphthalide Protocol coli, confirming its catalytic versatility. The absence of a glutamine amidotransferase activity suggests that HisFCg evolved a novel mechanism to bypass the need for HisH. This finding has profound implications for industrial applications, as it allows histidine production independent of glutamine metabolism—a major metabolic burden.
Histidinol-phosphate phosphatase (HisN) catalyzes the dephosphorylation of L-histidinol phosphate (Hol-P) to yield L-histidinol.PMID:35216324 In C. glutamicum, this activity is encoded by hisN, a gene previously unidentified due to lack of sequence homology to known phosphatases. HisNCg belongs to a new class of phosphatases unrelated to either the DDDD-superfamily or PHP-superfamily. Instead, it clusters within bacterial-like inositol monophosphatases (IMPase), sharing high sequence similarity with proteins from high-GC Gram-positive bacteria. Four homologues exist in the genome (cg0911, cg2090, cg2298, cg0967), all containing conserved IMPase domains.
Deletion of hisN results in partial auxotrophy, indicating functional redundancy among the four homologues. One of them likely compensates for the loss of HisN activity, possibly through overlapping substrate specificity. Unlike bifunctional Hol-P phosphatases found in E. coli and S. typhimurium, HisN operates independently, allowing for modular regulation. This separation may facilitate fine-tuning of pathway flux without affecting earlier steps.
The final two steps are catalyzed by a single enzyme: histidinol dehydrogenase (HisD). It oxidizes L-histidinol to L-histidinal, then further oxidizes it to L-histidine, consuming two molecules of NAD⁺. HisDCg acts as a homodimer, with each subunit contributing to the active site. The enzyme is metal-dependent, likely requiring Zn²⁺ or Mn²⁺. Structural modeling based on E. coli HisD shows a similar dimeric arrangement, with active sites located at the subunit interface. Residues from both subunits coordinate the substrate and metal ion, while NAD⁺ binds to one subunit only. A Bi-Uni Uni-Bi ping-pong mechanism is proposed: L-histidinol binds first, followed by NAD⁺; NADH+H⁺ is released while L-histidinal remains bound; then a second NAD⁺ binds and is reduced, releasing another NADH+H⁺ and yielding L-histidine.
Kinetic analysis confirms high specificity for L-histidinol, with no detectable activity toward analogues. The enzyme is essential for histidine production, and its deletion leads to complete auxotrophy. Its role in the final steps positions it as a potential bottleneck in the pathway, making it a candidate for overexpression or stabilization in engineered strains.
Other enzymes also exhibit unique characteristics. Phosphoribosyl-ATP pyrophosphatase (HisE) and phosphoribosyl-AMP cyclohydrolase (HisI) are encoded by separate genes in C. glutamicum, unlike in E. coli where they are fused. HisECg forms a dimer, consistent with M. tuberculosis HisEMt. The bifunctional His(IE) enzyme is absent in Actinobacteria, indicating horizontal gene transfer events during evolution.
5ProFAR isomerase (HisA) catalyzes an internal redox reaction converting 5ProFAR to PRFAR. HisACg acts as a monomer, adopting an (α/β)₈ barrel fold. Deletion of hisA causes strict histidine auxotrophy, confirming its essentiality. No evidence supports dual functionality in tryptophan biosynthesis, implying the presence of a separate phosphoribosylanthranilate isomerase encoded by trp(CF).
Imidazoleglycerol-phosphate dehydratase (HisB) converts IGP to imidazole-acetol phosphate (IAP) via a non-enzymatic ketonization step. HisBCg functions as a monomer and is structurally distinct from the bifunctional enzyme in E. coli. Its independence allows for decoupled regulation of early and late pathway steps.
In summary, the enzymatic network of histidine biosynthesis in C. glutamicum is marked by structural innovation, functional flexibility, and evolutionary divergence. The dispensability of hisH, the uniqueness of HisN, and the modularity of HisD offer compelling opportunities for strain engineering. Targeted modifications—such as feedback-resistant HisG mutants, overexpression of HisD, or optimization of transporter expression—can dramatically enhance histidine titers. Future work should focus on high-resolution structural characterization of HisFH and HisN, combined with in vivo dynamics studies, to fully exploit these insights for industrial biotechnology.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com